We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
+3.04%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$168M
AUM Growth
-$3.01M
Cap. Flow
-$7.02M
Cap. Flow %
-4.17%
Top 10 Hldgs %
59.32%
Holding
59
New
3
Increased
23
Reduced
23
Closed
4

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$4.36M
2
PRLB icon
Protolabs
PRLB
+$2.39M
3
META icon
Meta Platforms (Facebook)
META
+$1.72M
4
ET icon
Energy Transfer Partners
ET
+$400K
5
CAT icon
Caterpillar
CAT
+$205K

Top Sells

Rank Stock Value
1
PCYC
PHARMACYCLICS INC
PCYC
+$7.11M
2
SBUX icon
Starbucks
SBUX
+$4.15M
3
NDLS icon
Noodles & Co
NDLS
+$1.18M
4
POWI icon
Power Integrations
POWI
+$1.17M
5
WOLF icon
Wolfspeed
WOLF
+$814K

Sector Composition

Rank Sector Weight
1 Healthcare 38.69%
2 Technology 23.8%
3 Consumer Discretionary 20.19%
4 Communication Services 8.85%
5 Industrials 2.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TTSH
26
DELISTED
Tile Shop Holdings
TTSH
$825K 0.49%
58,166
+40
+0.1% +$538
BMY icon
27
Bristol-Myers Squibb
BMY
$128B
$791K 0.47%
11,890
+257
+2% +$16.9K
HD icon
28
Home Depot
HD
$335B
$729K 0.43%
6,562
-125
-2% -$14K
BA icon
29
Boeing
BA
$167B
$657K 0.39%
4,735
+110
+2% +$16K
ABT icon
30
Abbott
ABT
$182B
$611K 0.36%
12,442
-5
-0% -$240
JNJ icon
31
Johnson & Johnson
JNJ
$641B
$525K 0.31%
5,387
-45
-0.8% -$4.51K
NSC icon
32
Norfolk Southern
NSC
$77.1B
$495K 0.29%
5,665
+174
+3% +$17K
WBA
33
DELISTED
Walgreens Boots Alliance
WBA
$490K 0.29%
5,798
+145
+3% +$12.5K
LLY icon
34
Eli Lilly
LLY
$1.07T
$466K 0.28%
5,576
+237
+4% +$18.1K
PFE icon
35
Pfizer
PFE
$141B
$442K 0.26%
13,904
– –
T icon
36
AT&T
T
$167B
$435K 0.26%
16,202
+159
+1% +$4.11K
ET icon
37
Energy Transfer Partners
ET
$68.5B
$415K 0.25%
25,852
+11,926
+86% +$400K
NEE icon
38
NextEra Energy
NEE
$185B
$379K 0.23%
15,464
– –
PAYX icon
39
Paychex
PAYX
$41.1B
$348K 0.21%
7,421
+37
+0.5% +$1.81K
SLB icon
40
SLB Ltd
SLB
$76.5B
$339K 0.2%
3,929
+300
+8% +$27.1K
JPM icon
41
JPMorgan Chase
JPM
$947B
$337K 0.2%
4,974
+190
+4% +$12.4K
TROW icon
42
T. Rowe Price
TROW
$25.5B
$319K 0.19%
4,107
+200
+5% +$16.1K
MRK icon
43
Merck
MRK
$323B
$314K 0.19%
5,778
-63
-1% -$3.53K
VZ icon
44
Verizon
VZ
$198B
$300K 0.18%
6,445
-90
-1% -$4.41K
NUE icon
45
Nucor
NUE
$56.4B
$291K 0.17%
6,614
– –
IP icon
46
International Paper
IP
$22.5B
$252K 0.15%
5,596
+90
+2% +$4.46K
CVX icon
47
Chevron
CVX
$378B
$232K 0.14%
2,410
– –
TGT icon
48
Target
TGT
$63.7B
$229K 0.14%
2,810
+110
+4% +$8.9K
COST icon
49
Costco
COST
$422B
$228K 0.14%
1,685
+85
+5% +$12.2K
DE icon
50
Deere & Co
DE
$169B
$220K 0.13%
2,271
-100
-4% -$9.1K
1
2
3

Similar funds

AWCI
Alpine Woods Capital Investors Purchase, New York $417M AUM 26.83% 1-Year Est. Return
KPWG
KFA Private Wealth Group Tysons, Virginia $417M AUM 16.82% 1-Year Est. Return
ACM
Alight Capital Management New York $417M AUM 98.18% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $418M AUM 80.77% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
SCP
Stevens Capital Partners Omaha, Nebraska $416M AUM 18.93% 1-Year Est. Return

Bender Robert & Associates's Q2 2015 Portfolio in Review

As of Q2 2015, Bender Robert & Associates held 59 positions worth $168M, down 1.8% from $171M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Bender Robert & Associates withdrew a net $7.02M in Q2 2015, closing 4 positions and reducing 23 holdings. Its most notable exit was PHARMACYCLICS INC, an estimated $7.11M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 33% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Bender Robert & Associates opened a new position in AbbVie worth $4.49M.

  • Bender Robert & Associates's largest Q2 2015 buy was AbbVie: 66,810 shares worth $4.49M.
  • Bender Robert & Associates added most to Meta Platforms (Facebook) in Q2 2015, an estimated $1.72M increase.
  • Bender Robert & Associates's biggest Q2 2015 reduction was Starbucks, cutting an estimated $4.15M.
  • Bender Robert & Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $7.11M.
  • Bender Robert & Associates's ten largest holdings make up 59% of its $168M portfolio in Q2 2015.
  • Bender Robert & Associates opened 3 new positions and closed 4 in Q2 2015.
  • Bender Robert & Associates's portfolio value fell 1.8% quarter-over-quarter to $168M.

Based on Bender Robert & Associates's 13F filing for Q2 2015, filed 10 Aug 2015.